In 2012 at SXSW, health and healthcare put on a good showing in terms of the panels, talks and companies present and promoting themselves. This document provides a short roundup of start-ups that I saw presenting during the “start-up accelerator” portion of the conference. Here are some thoughts on some of these companies. Medify Medify […]Read More SXSW Interactive 2012: Health-related start-up roundup.
Social Media in Healthcare, just another hype? Presentation by Lucien Engelen – Director Radboud REshape & Innovation Center. – NL (@Zorg20) Lucien Engelen Keynote Doctors 2.0 View more presentations from Lucien EngelenRead More Belatedly, my favourite presentation from Doctors 2.0 and You
I was fortunate enough to attend the South By SouthWest Interactive conference (colloquially ‘Southby’ or SXSW), which benefited from a health ‘track’ that focused on innovation and digital in healthcare. At the event, I attended a number of panels and I would like to share my notes on some of the panels here. So, I […]Read More SXSW feature: The secret life of behaviour change
A quick apology to readers of this blog. I really enjoy writing here, but the past month has thrown up a number of challenges. One of these challenges is actually finding something interesting and, importantly, new, to write about. There are so many bloggers out there that I feel I would be doing you a […]Read More Balloon animals
I probably don’t need to tell you that there has been buzz recently about the new FDA guidance on social media that is predicted to appear in this year Indeed, John Mack predicted that the guidance would be issued in sections, and he puts forward a theory that guidance on short-format or space-limited communications will […]Read More Social media sharing for pharma
I want to pick up a bit more on the closing remark from my DigiPharm Europe 2010 posts. If you recall, I said: To survive in this landscape, Pharma must make inroads into developing a digital strategy – and by that I mean integrate your digital tactics into your overall strategic plan, and at the […]Read More When is digital strategy not digital strategy?
Here’s my final post on the #DigiPharm narrative. Part 7! Again, I am reporting on selected sessions from Day 2, ones that I found of note or interest. You can read the twitterstream for more information on the presentations not covered here. Part 1 Part 2 Part 3 Part 4 Part 5 Part 6 Still […]Read More DigiPharm Europe 2010 Pt 7
So here’s the penultimate part of this week-long series. Today I am focusing on the morning session of Day 2 of DigiPharm 2010 and the concluding blog post tomorrow will cover the afternoon session. I will not cover every presentation from Day 2, just the ones that had impact with the audience. Part 1 Part […]Read More DigiPharm Europe 2010 Pt 6
Once more unto the DigiPharm breach. Part 1 Part 2 Part 3 Part 4 Part 6 Part 7 Building up to reportable adverse events When last we spoke, I covered patient community discussions. We now turn our attention to reportable adverse events and the Internet presented by Daniel Ghinn and Paul Grant. They start by […]Read More DigiPharm Europe 2010 Pt 5
And to the next instalment of this series on DigiPharm Europe 2010. Part 1 Part 2 Part 3 Part 5 Part 6 Part 7 When is a community not a community? The session entitled “Community management in Pharma” was presented by René Vvan den Bos and Erik Van der Zijden. They focused on mythical ailment […]Read More DigiPharm Europe 2010 Pt 4